The role of vasodilating agents in the treatment of chronic heart failure.
D002302:Cardiac Output / Q000187:drug effects; D002908:Chronic Disease; D004280:Dobutamine / Q000627:therapeutic use; D006333:Heart Failure / Q000188:drug therapy*; D006801:Humans; D009119:Muscle Contraction / Q000187:drug effects; D009599:Nitroprusside / Q000627:therapeutic use; D010646:Phentolamine / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011654:Pulmonary Edema / Q000188:drug therapy; D014655:Vascular Resistance / Q000187:drug effects; D014665:Vasodilator Agents / Q000627:therapeutic use*
D014665:Vasodilator Agents; D009599:Nitroprusside; D004280:Dobutamine; D011224:Prazosin; D010646:Phentolamine